Bain Capital Life Sciences Investors, LLC Natera, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$37.55 - $62.64 $11.3 Million - $18.8 Million
-300,000 Reduced 42.85%
400,197 $25.1 Million
Q1 2023

May 15, 2023
SELL
$36.57 - $58.29 $25.6 Million - $40.8 Million
-699,803 Reduced 49.99%
700,197 $38.9 Million
Q4 2022

Feb 14, 2023
BUY
$34.17 - $47.91 $47.8 Million - $67.1 Million
1,400,000 New
1,400,000 $56.2 Million

Others Institutions Holding NTRA

# of Institutions
526
Shares Held
119M
Call Options Held
308K
Put Options Held
191K
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email